Menu

BioNTech SE BNTX

Full chart Compare
Set alert

Price alert · BNTX

All alert types
85.86 USD -4.84 (-5.34%)

At closeNov 6, 2026, 7:40 AM EST

85.71 -0.15 -0.17%

Pre-market · Nov 6, 7:40 AM ET

85.80 Day range 90.83
79.52 52-week range 124.00
YTD
-9.81%
1 year
-16.99%

Revenue & Expenses

Revenue → Gross Profit: $2.14BGross Profit → Expenses: $2.14BRevenue → Cost of Revenue: $616.47MExpenses → Selling, General & Admin: $698.20MExpenses → Research & Development: $2.02BExpenses → Other Operating Expenses: $44.00MExpenses → Interest Expense: $13.64MExpenses → Other Expenses: $371.82MExpenses → Income Tax: $81.93MNet Loss → Expenses: $1.09BGross Profit$2.14BNet Loss$1.09BCost of Revenue$616.47MExpenses$3.23BSelling, General & Admin$698.20MResearch & Development$2.02BOther Operating Expenses$44.00MInterest Expense$13.64MOther Expenses$371.82MIncome Tax$81.93MRevenue$2.76B

Latest period ending Dec 31, 2025 · select a line to chart its full history

BNTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.87B2.75B3.82B17.31B18.98B
2.23B2.21B3.22B14.32B16.07B
-1.40B-1.31B690.40M12.64B15.28B
-1.14B-665.30M930.30M9.43B10.29B
-4.70-2.773.8337.7739.63
BNTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.68B9.76B11.66B13.88B1.69B
21.99B22.53B23.01B23.28B15.83B
2.76B3.12B2.76B3.22B3.94B
714.00M1.74B673.10M1.00B1.50B
19.22B19.41B20.25B20.06B11.89B
BNTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
456.00M207.70M5.37B13.58B889.70M
-2.47B-2.08B-6.95B-35.30M-566.10M
-52.90M-45.90M-778.60M-1.42B94.20M
-170.60M-285.30M-250.10M-362.70M-150.60M
-2.07B-1.92B-2.36B12.12B417.80M